You are viewing: India Single-use Bioprocessing Market analysis

The India Single-use Bioprocessing Market was valued at $224.8 Million in 2025 and projected to reach to $414.1 Million by 2030, representing a compound annual growth rate of 13.0%. India's single-use bioprocessing market is poised for significant growth as the country consolidates its position as a global biopharmaceutical manufacturing destination.

India Single-use Bioprocessing Market Trends and Insights

  • India is emerging as a critical hub for biopharmaceutical manufacturing, driven by increasing investments in contract manufacturing organizations (CMOs) and a growing demand for cost-effective bioprocessing solutions.
  • The adoption of single-use technologies in India is accelerating as domestic and multinational biopharmaceutical companies seek to reduce capital expenditure and operational complexity. The market growth in India is underpinned by rising government support for biotechnology infrastructure, expanding vaccine and biologics production capacity, and the country's competitive advantage in contract manufacturing.
  • India's skilled workforce and regulatory improvements have positioned the nation as an attractive destination for single-use bioprocessing adoption.
  • Between 2025 and 2030, India is expected to witness significant capacity additions in bioreactors, filtration systems, and storage solutions, reflecting the sector's maturation and increasing sophistication in bioprocess development..

Key Market Statistics

  • CAGR (2025-2030) 13.0% CAGR
  • Market Size, 2025 ~USD 224.8 Million
  • Forecast, 2030 ~USD 414.1 Million
  • Country India

India Single-use Bioprocessing Market Overview

Rapid Market Growth :

India's single-use bioprocessing market is expanding at a 13% CAGR, growing from USD 224.8 million in 2025 to USD 414.1 million by 2030, reflecting strong demand for biopharmaceutical manufacturing solutions.

CMO Hub Expansion :

India is establishing itself as a critical contract manufacturing organization (CMO) hub, with increasing investments from global biopharmaceutical companies seeking cost-effective and scalable bioprocessing capabilities.

Cost-Effective Solutions :

Single-use bioprocessing adoption in India is driven by the need for cost-efficient manufacturing alternatives, enabling domestic and international companies to reduce operational expenses while maintaining quality standards.

Regulatory Infrastructure Development :

India's strengthening regulatory framework and WHO-GMP certifications are enhancing the credibility of Indian bioprocessing facilities, attracting multinational pharmaceutical and biotechnology companies to establish operations.

India Single-use Bioprocessing Market Dynamics

  • The convergence of skilled workforce availability, competitive manufacturing costs, and government support for biotechnology initiatives creates a favorable environment for market expansion.
  • Increasing investments in CMO infrastructure and technological upgrades are expected to drive adoption of single-use systems across vaccine production, monoclonal antibodies, and recombinant protein manufacturing. The market will be further propelled by rising domestic demand for biologics, growing partnerships between Indian manufacturers and global pharmaceutical companies, and the shift toward flexible, scalable bioprocessing solutions.
  • Enhanced regulatory compliance and quality certifications will strengthen India's competitive advantage, positioning the country as a preferred destination for contract manufacturing and technology transfer in the single-use bioprocessing sector..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • India's single-use bioprocessing market is valued at USD 224.8 million in 2025 and is forecast to grow to USD 414.1 million by 2030, representing a 13.0% CAGR.
    • India is positioning itself as a global manufacturing hub for biopharmaceuticals, with single-use technologies enabling cost-effective and flexible production.
    • Government initiatives and regulatory support in India are accelerating the adoption of single-use bioprocessing systems across CMOs and domestic biopharmaceutical companies.
    • India's competitive labor costs and technical expertise make the country an attractive destination for multinational companies to establish or expand single-use bioprocessing operations.

    Single-use Bioprocessing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment CONSUMABLES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 13.3% from 2025 to 2030
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 18.03 (2025)
    Revenue Forecast (Billions) ~USD 33.67 (2030)
    Segments Covered Product, Type, Scale Range, Scale

    India Single-use Bioprocessing Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Equipment

    By Type

    • 2D Bags & Containers
    • 3D Bags & Containers
    • Bag Assemblies
    • Bottle Assemblies
    • Filtration Assemblies
    • Mixing System Assemblies
    • Other Assemblies
    • Other Single-Use Consumables
    • Other Single-Use Equipment
    • Single-Use Assemblies
    • Single-Use Bags & Containers
    • Single-Use Bioreactors
    • Single-Use Chromatography Columns
    • Single-Use Chromatography Systems
    • Single-Use Filters
    • Single-Use Filtration Systems
    • Single-Use Mixing Systems
    • Single-Use Sensors

    By Scale Range

    • 101–500 L Bioreactors
    • 11–100 L Bioreactors
    • 501–1,500 L Bioreactors
    • >1,500 L Bioreactors
    • =10 L Bioreactors

    By Scale

    • Manufacturing-Scale Filtration Systems
    • Manufacturing-Scale Mixing Systems
    • Pilot-Scale Filtration Systems
    • Pilot-Scale Mixing Systems
    • R&D-Scale Filtration Systems
    • R&D-Scale Mixing Systems

    Target Audience

    • Biopharmaceutical Manufacturers : Global and domestic pharma companies seeking to establish or expand manufacturing operations in India need market insights to identify CMO partners, assess capacity, and evaluate cost-benefit advantages.
    • Contract Manufacturing Organizations (CMOs) : Indian and international CMOs require detailed market data to benchmark their position, identify growth opportunities, and develop strategic expansion plans within India's bioprocessing sector.
    • Equipment & Technology Suppliers : Bioprocessing equipment manufacturers and technology providers need India-specific market intelligence to identify customer segments, assess demand for single-use systems, and plan market penetration strategies.
    • Investment & Private Equity Firms : Investors evaluating opportunities in India's biotech and pharmaceutical sectors require comprehensive market analysis to assess growth potential, identify acquisition targets, and make informed funding decisions.
    • Regulatory & Consulting Bodies : Regulatory consultants, quality assurance firms, and business advisory organizations need India-focused market data to guide clients through compliance requirements and market entry strategies.

    Key Companies in the India Single-use Bioprocessing Market

    CompanyHQOwnershipStrongest segments

    Reasons to Buy this Report

    • Market Size & Growth Projections : Access precise valuation data for India's single-use bioprocessing market (USD 224.8M in 2025, USD 414.1M by 2030) with detailed CAGR analysis to support investment decisions and business planning.
    • India-Specific Competitive Landscape : Understand the competitive dynamics of India's CMO sector, including key players, market consolidation trends, and differentiation strategies specific to the Indian bioprocessing ecosystem.
    • Regulatory & Compliance Insights : Gain comprehensive knowledge of India's regulatory environment, WHO-GMP certifications, and compliance requirements essential for market entry and operational success in Indian bioprocessing.
    • Investment Opportunity Assessment : Evaluate investment potential in Indian bioprocessing infrastructure, technology partnerships, and CMO expansion opportunities with data-driven market analysis and growth forecasts.
    • Strategic Market Positioning : Develop targeted go-to-market strategies for India by understanding regional demand drivers, customer preferences, and emerging opportunities in vaccine production and biologics manufacturing.

    Frequently asked questions

    What is the current market size of single-use bioprocessing in India?

    India's single-use bioprocessing market was valued at USD 224.8 million in 2025 and is expected to grow at a 13.0% CAGR through 2030.

    What is driving the growth of single-use bioprocessing in India?

    Growth in India is driven by increasing CMO investments, government biotechnology support, rising vaccine and biologics production, and the country's cost-competitive manufacturing advantage.

    What is the forecast market size for India by 2030?

    India's single-use bioprocessing market is projected to reach USD 414.1 million by 2030, reflecting strong demand for flexible and scalable bioprocessing solutions.

    Why is India becoming a hub for single-use bioprocessing?

    India offers skilled workforce, lower operational costs, improving regulatory frameworks, and established CMO infrastructure, making it attractive for biopharmaceutical manufacturing.

    Which segments of single-use bioprocessing are growing fastest in India?

    Bioreactors, filtration systems, and storage solutions are experiencing the fastest growth in India as companies expand vaccine and biologics production capacity.

    RESEARCH METHODOLOGY

    This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-use bioprocessing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioprocessing market. The secondary sources used for this study include the World Health Organization (WHO), the National Institutes of Health (NIH), the United States Food and Drug Administration (US FDA), the National Institute for Bioprocessing Research and Training (NIBRT), the Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), the European Patent Office (EPO), Pharmaceuticals Export Promotion Council of India (Pharmexcil), India Brand Equity Foundation (IBEF), Biotechnology Innovation Organization (BIO), the National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, BioProcess International, Journal of Bioprocessing and Biotechni ques, BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    After acquiring foundational knowledge about the global single-use bioprocessing market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs) & contract research organizations (CROs), and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

    These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

    The following is a breakdown of the primary respondents:

    Single-use Bioprocessing Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    After arriving at the overall market size from the estimation process, the total market was split into several segments and subsegments.

    Single-use Bioprocessing Market

    Data Triangulation

    After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Single-use bioprocessing refers to the use of disposable, pre-sterilized equipment and consumables in the production of biopharmaceutical products. Single-use technologies (SUTs) include a range of products, such as bioreactors, mixers, filters, tubing, connectors, and storage bags, all designed for one-time use. Key benefits of single-use bioprocessing include reduced risk of cross-contamination, low capital and operational costs, faster turnaround times, and greater flexibility in manufacturing. These advantages make single-use systems particularly attractive to produce biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.

    Stakeholders

    • Single-use bioprocessing equipment and consumables manufacturing companies
    • Single-use bioprocessing equipment and consumables distributors
    • Pharmaceutical and biotechnology companies
    • Contract manufacturing companies (CMOs)
    • Contract research organizations (CROs)
    • Academic and research institutes
    • Life science companies
    • Market research and consulting firms
    • Venture capitalists and investors
    • Government organizations
    • Private research firms

    Report Objectives

    • To define, describe, and forecast the single-use bioprocessing market, by product, application, workflow, molecule type, and end user, in terms of value
    • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
    • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall single-use bioprocessing market
    • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile key players in the single-use bioprocessing market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments in the single-use bioprocessing market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
    • To benchmark players within the single-use bioprocessing market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

     

    Get the Full Single-use Bioprocessing Market Report

    Full forecast, segment splits, and company analysis for all Single-use Bioprocessing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status